Skip to main content

Table 8 Evaluation of HCVcAg assay performance in prediction of treatment response at the 12th and 24th week among the studied groups

From: Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

  Sensitivity Specificity PPV NPV Accuracy
HCVcAg at the 12th week (Peiu/ml) 100% 100% 100% 100% 100%
HCVcAg at the 24th week (Peiu/ml) 100% 100% 100% 100% 100%